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ABSTRACT 
OBJECTIVE: The objective of this study is to identify factors associated with the preference for 
purchasing generic drugs in a medium-sized municipality in Southern Brazil. 
METHODS: We have analyzed data from a population-based cross-sectional study conducted in 
2012 with a sample of 2,856 adults (≥ 20 years old). The preference for purchasing generic drugs 
was the main outcome. The explanatory variables were the demographic and socioeconomic 
variables. Statistical analyses included Poisson regressions. 
RESULTS: The preference for purchasing generic drugs was 63.2% (95%CI 61.4–64.9). The variables 
correlated with this preference in the fully adjusted models were: male (prevalence ratio 
[PR] = 1.08; 95%CI 1.03–1.14), age of 20–39 years (PR = 1.10; 95%CI 1.02–1.20), low socioeconomic 
status (PR = 1.15; 95%CI 1.03–1.28), and good knowledge about generic drugs (PR= 4.66; 95%CI 
2.89–7.52). Among those who preferred to purchase generic drugs, 55.1% have reported accepting 
to replace the prescribed drug (if not a generic) with the equivalent generic drug. Another correlate 
of the preference for purchasing generic drugs was because individuals consider their quality 
equivalent to reference medicines (PR = 2.15; 95%CI 1.93–2.41). 
CONCLUSIONS: Knowledge about generic drugs was the main correlate of the preference 
for purchasing generic drugs. The greater the knowledge or positive perception about generic 
drugs, the greater is the preference to purchase them. Therefore, educational campaigns for 
healthcare professionals and consumers appear to be the best strategy for expanding the use of 
generic drugs in Brazil. 
DESCRIPTORS: Drugs, Generic, economics. Patient Medication Knowledge. Consumer Behavior. 
Socioeconomic Factors. Cross-Sectional Studies. 
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INTRODUCTION 
The challenges for expanding access to medicines and reducing expenditures on these products 
have resulted in major changes in the Brazilian pharmaceutical sector. The establishment 
of policies such as the National Drug Policy25 and the National Policy of Pharmaceutical 
Assistance26 are initiatives to ensure access to medicines and to promote their rational use. 
The Generic Drug Law implemented in Brazil in 199925 also aims to facilitate access of 
persons to drug treatment, offering medicines with assured quality and low prices, reducing 
household expenditure on them2. 
Since the implementation of the Generic Drug Law25, three types of drugs are being marketed 
in Brazil: reference drugs (innovative drugs, brands), generic drugs (drugs designated by 
the Brazilian Nonproprietary Name [DCB], usually produced after the expiration of patent 
protection, which must be interchangeable with the reference drug), and similar medicines 
(not interchangeable with the reference drug and marketed under a brand name)25. 
Most studies on generic drugs have focused on the knowledge, beliefs, and perceptions 
of pharmacists, physicians, and patients about these drugs10,11. We have relatively good 
knowledge on users of generic drugs in Brazil8,27,30 and abroad20,21, but the literature of upper 
middle income countries lacks studies on the factors that influence the purchasing decision 
of consumers between generic and brand drugs14,24,32. 
In Brazil, according to the Brazilian Association of Generic Drug Industries (Pro Genericos)a, 
generic drugs reached 28% of the sales volume in units sold and 24.8% of the total financial 
value, considering data from the Intercontinental Marketing Services (IMS) Health, in 2014. 
Studies on the prevalence of the use of generic drugs have found values ranging from 3.6% to 
45%8,9,27,35. It is worth noting that studies carried out earlier than 2007 found lower prevalence 
of use of generic drugs8,9,35 when compared to a national study conducted in 201327. 
Studies from Italy12 and Portugal29 have found that a lack of confidence in bioequivalence tests 
directly implies the reluctance of some physicians to prescribe generic drugs, resulting in a lack 
of information for users and, consequently, low confidence in the effectiveness of these drugs. 
However, among those using generic drugs, most report being satisfied with the results9,23. 
Purchasing preferences can be understood as related to the concept of acceptability, 
a dimension of access to medicines that expresses the balance between the characteristics 
of products and services and the expectations and needs of users7. 
Hanson et al.15 provides an integrated view of health systems with five levels (individuals, 
families and communities, provision of health services, health sector, intersectoral policies, 
and international and regional level)15. This proposal entails the identification of the main 
barriers to access services and products at each level, as well as their interactions. The case of 
access to generic drugs is exemplary in this regard, since it involves aspects at the individual 
level, such as preferences and acceptability, and aspects outside the health sector, such as 
performance of the retail trade and advertisement of the producers of the drug. 
This study aims to identify factors associated with the preference for purchasing generic 
drugs in a medium-sized municipality in Southern Brazil. 
METHODS 
A population-based cross-sectional study was carried out in the municipality of Pelotas, in the 
State of Rio Grande do Sul, Brazil. The city has approximately 328,000 inhabitants, of which 
93.2% live in urban areas. Its Human Development Index in 2010 (HDI 2010) was 0.739 
(Population Census of 2010 of the Brazilian Institute of Geography and Statistics – IBGE). 
This study was part of the Research Consortium aiming to assess the health of adolescents, 
adults, and older adults in the city6. Data were collected from February to June 2012. 
a Associação Brasileira das 
Indústrias de Medicamentos 
Genéricos. Mercado dos 
medicamentos genéricos. 
São Paulo; 2015. 
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Sampling process was carried out in multiple stages. The primary sampling unit was 495 
census tracts (delimited areas covering approximately 300 households each). Of these tracts, 
130 were selected and stratified by socioeconomic status to ensure coverage of the entire city. 
The secondary sampling unit was the household. In each sampled tract, between 50 and 60 
households were systematically selected, proportionate to the size of the tract, amounting 
to 1,722 households in the sample. In each selected household, all individuals aged 20 years 
or older were invited to participate, except those with severe mental disability that made it 
impossible to answer to the questionnaire. 
Sample size was based on two different calculations: estimated prevalence of “preference 
for purchasing generic drugs” and study of association between “preference for purchasing 
generic drugs” and independent variables. Considering the final sample size (n = 2,925), 
we could estimate prevalence rates between 32% and 40%, with an error margin of 
± 5 percentage points and a 95% confidence level. In addition, relative risks of 1.15 or great 
could be detected with 80% power and 95% confidence level. 
A pre-tested and standardized questionnaire was used to assess the variables of interest. 
The main outcome variable was based on a single question: “When you go to pharmacy to 
purchase medicines, do you prefer to purchase generic drugs?”. 
Independent variables were: a) demographic and socioeconomic: sex, age (20–39, 40–59, 
≥ 60 years); skin color/race (white, black, yellow, brown, or indigenous), education (0–4, 5–8, 
≥ 9 years of education); asset index (AI), based on the ownership of 13 assets (education of the 
household head, number of rooms used to sleep, number of bathrooms, colored television, 
car, radio, refrigerator or freezer, DVD, telephone line, desktop, air conditioner or split air 
conditioner, vacuum cleaner, and domestic housemaids; first – 20% poorest –, second, third, 
fourth, and fifth quintiles – 20% wealthiest)5; b) health: drugs used for chronic or eventual 
diseases; self-reported health status (excellent or very good, good or fair, poor); c) knowledge 
on generic drugs, using a score. This score, ranging from zero to three, included the answers 
to questions about the price of generic drugs as compared to the reference drug (the correct 
answer was “lower”), the quality of generic drugs as compared to the reference drug (the correct 
answer was “the same”), and the correct identification of at least one of the characteristics that 
differentiate the packaging of generic drugs from other drugs (Generic law number printed on 
the packaging, the letter “G” for generic drugs, or the words “generic drugs”). These questions 
composing the score were applied before the question about the outcome. 
The ability to recognize the packaging of generic drugs was also tested. First, respondents 
were presented with the image of a reference drug (Voltaren). Then, the image of the 
packaging of the similar drug was shown (Diclosódico) and we asked whether or not it 
was a generic drug (correct answer = no). After, the image of the packaging of the generic 
drug was presented (diclofenaco de sódio – diclofenac sodium) and we asked if the drug was 
generic (correct answer = yes). This test was applied after the question about the outcome. 
The ability to recognize the packaging of generic drugs was always assessed in the same 
order (reference drug, similar drug, and generic drug) and just once. 
Analyses were conducted in Stata 12.1b, considering the design effect and using the set of svy 
commands specific to the analysis of surveys based on complex sampling strategies. Bivariate 
analyses were performed to calculate the prevalence of the outcome in each category of predictors, 
as well as unadjusted prevalence ratios and their 95% confidence intervals. For statistical 
significance, we used the p-values obtained by the Wald test for heterogeneity or linear trend. 
In the adjusted analyses, considering our dichotomous outcome with a high prevalence, 
a Poisson regression with robust adjustment for variance was used4. Analyses were based 
on a hierarchical model34 (Figure 1). Therefore, the effect of each predictor on the outcome 
was adjusted for all variables in its same level or above in the causal pathway. Demographic 
(sex, age) and socioeconomic variables (education, asset index) were placed at the distal 
level of determination. On the second level, we included self-reported health status and in 
the third level, the knowledge about generic drugs. 
b StataCorp. Stata Statistical 
Software: Release 12. College 
Station, TX: StataCorp LP; 2011. 
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An informed consent was obtained from each subject and the research protocol was approved 
by the Ethics Committee of the Faculdade de Medicina da Universidade Federal de Pelotas. 
RESULTS 
Within the sampled households, we located 3,379 eligible individuals, of which 2,925 (86.6%) 
answered the questionnaire. For this specific analysis, the sample size was 2,856 (84.5%), because 
some participants had missing values for the outcome variable. Losses and refusals had a higher 
proportion for males (56.6%), but they were similar to the sample in relation to average age. 
The preference for purchasing generic drugs was 63.2% (95%CI 61.4–64.9). Table 1 describes 
the sample according to the demographic, socioeconomic, and health variables and the self-
assessment score of knowledge about generic drugs. Most participants were female (59.2%), the 
mean age was 45.5 years (SD = 16.4), most were white (80.1%), more than half had nine or more 
years of study (54.7%) and a large fraction of the sample (64.4%) declared to be in good health. 
Most participants were aware that generic drugs were cheaper than reference medicines 
(88.1%), had an equivalent quality (69.8%), and were able to correctly identify the 
characteristics that differentiate the packaging of generic drugs from other drugs (76.6%). 
The score created based on this knowledge showed that 52% of respondents achieved 
maximum value. In addition, 72% of the participants could correctly distinguish the 
packaging of a similar drug from that of a generic medicine (Table 1). 
Table 2 shows the prevalence and factors associated with the preference for purchasing 
generic drugs. Men had a greater preference for purchasing generic drugs compared to 
women (PR = 1.08; 95%CI 1.03–1.14), and the effect remained significant after adjusting for 
age, education, and asset index. 
The preference for purchasing generic drugs was inversely associated with age, both in the 
crude (p < 0.001) and adjusted (p = 0.021) analyses. The preference for purchasing generic 
drugs was 57.4% among persons with up to four years of education, 66.5% between five to eight 
years of education, and 63.3% among those with nine or more years of education (p = 0.008). 
After adjustment, there was a trend of increasing preference for purchasing generic drugs 
as the asset index decreased (p = 0.033). 
Self-reported health was associated with the preference for purchasing generic drugs (p = 0.026). 
The participants who reported their health as “poor” were more likely to prefer generic drugs 
Figure 1. Hierarchical model of analysis on the determinants of “prevalence of preference for purchasing 
generic drugs”. 
Demographic variables 
Sex Age
Skin Color/Race 
Socioeconomic variables 
Education
Economic class 
Use of drugs for chronic or eventual diseases 
Self-reported health status
Preference for purchasing generic drugs
 
Knowledge of the generic drug
Incorrect visual identification of generic drugs
Score of knowledge about generic drugs:
- lower price of generic drugs
- equivalent quality of generic drugs
- correct identification of the characteristics that differentiate 
the packaging of generic drugs from other drugs
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Table 1. Description of adults according to the demographic and socioeconomic variables, health status, 
and knowledge about generic drugs. Pelotas, State of Rio Grande do Sul, Brazil, 2012.
Variable n %
Demographic and socioeconomic variables
Sex 
Female 1,691 59.2
Male 1,165 40.8
Age (years)
20–39 1,132 39.6
40–59 1,094 38.3
60 or more 630 22.1
Skin color/Race 
White 2,289 80.1
Black 345 12.1
Othera 222 7.8
Education (years of study)
0–4 495 17.4
5–8 796 27.9
9 or more 1,562 54.7
Asset index (quintiles)b
1st (20% poorest) 555 19.6
2nd 538 19.0
3rd 583 20.6
4th 588 20.7
5th (20% wealthiest) 570 20.1
Health status
Use of drugs for chronic or eventual diseases
Chronic 1,615 72.1
Eventual 625 27.9
Self-reported health status 
Excellent or very good 889 31.1
Good or fair 1,840 64.4
Poor 127 4.5
Knowledge about generic drugs
Lower price of generic drugs
No 339 11.9
Yes 2,517 88.1
Equivalent quality of generic drugs 
No 864 30.2
Yes 1,992 69.8
Identification of characteristics that differentiate the packaging of generic drugs 
Correct identification 2,189 76.6
Incorrect identification 667 23.4
Incorrect visual identification of similar medicines as generic drugs 
No 2,057 72.0
Yes 799 28.0
Score of knowledge about generic drugsc
0 76 2.7
1 350 14.9
2 942 33.0
3 1,488 52.1
Total 2,856 100
a Yellow, brown, or indigenous. 
b The maximum value of information lost was 22 missing (0.77%). 
c Score was composed of the answers to three questions: the price of generic drugs being lower, the quality 
of generic drugs being equivalent to the reference drug, and the correct identification of at least one of the 
characteristics that differentiated the packaging of generic drugs from other drugs.
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Table 2. Associated factors with preference for purchasing generic drugs in adults of Pelotas, State of 
Rio Grande do Sul, Brazil, 2012. (n = 2,856)
Levela Variable n (%)
Crude PRb 
(95%CI)
pc
Adjusted PRd 
(95%CI)
pc
Demographic and socioeconomic variables
1 Sex 0.004 0.003
Female 703 (60.3) 1 1
Male 1,101 (65.1) 1.08 (1.02–1.14) 1.08 (1.03–1.14)
1 Age (years) < 0.001 0.021
20–39 760 (67.1) 1.15 (1.06–1.24) 1.10 (1.02–1.20)
40–59 675 (61.7) 1.05 (0.96–1.15) 1.03 (0.94–1.12)
60 or more 369 (58.6) 1 1
1 Skin color/Race 0.565 -
White 1,436 (62.7) 1 -
Black 222 (64.4) 1.02 (0.93–1.13) -
Othere 146 (65.8) 1.05 (0.95–1.15) -
1 Education (years) 0.005 0.008
0–4 284 (57.4) 1 1
5–8 529 (66.5) 1.15 (1.06–1.26) 1.16 (1.05–1.27)
9 or more 988 (63.3) 1.10 (1.01–1.20) 1.13 (1.03–1.25)
1 Asset index (quintiles) 0.058 0.033
1st (20% poorest) 371 (66.9) 1.15 (1.03–1.27) 1.18 (1.06–1.33)
2nd 360 (66.9) 1.15 (1.03–1.28) 1.15 (1.02–1.30)
3rd 367 (63.0) 1.08 ( 0.96–1.21) 1.07 ( 0.95–1.21)
4th 365 (62.1) 1.06 (0.95–1.20) 1.06 (0.94–1.19)
5th (20% wealthiest) 332 (58.3) 1 1
Health status
2 Use of drugs for chronic or eventual diseases
Chronic 1,005 (63.8) 1 0.590 -
Eventual 570 (36.2) 0.98 (0.91–1.05) -
2 Self-reported health status
Excellent/Very good 555 (62.4) 1 0.071 1 0.026
Good/Fair 1,157 (62.9) 1.00 (0.95–1.07) 1.01 (0.95–1.08)
Poor 92 (72.4) 1.16 (1.02–1.32) 1.20 (1.05–1.38)
Incorrect visual identification of similar medicines as generic drugs
3 No 1,325 (64.4) 1.07 (1.00–1.16) 0.052 0.98 (0.92–1.05) 0.608
Yes 479 (60.0) 1 1
Score of knowledge about generic drugsf
3 0 14 (18.4) 1 < 0.001g 1 < 0.001g
1 120 (34.3) 1.86 (1.14–3.03) 2.01 (1.20–3.37)
2 514 (54.6) 2.96 (1.90–4.62) 3.27 (2.04–5.27)
3 1,156 (77.7) 4.22 (2.70–6.58) 4.66 (2.89–7.52)
Total 1,804 (63.2)
a Level according to the hierarchical model of analysis. 
b PR: Prevalence Ratio.
c Chi-Square test.
d Adjusted PR: adjusted for the same level as the variables and lower levels that had p ≤ 0.20. 
e Yellow, brown, or indigenous. 
f Score was composed of the answers to three questions: the price of generic drugs being lower, the quality 
of generic drugs being equivalent to the reference drug, and the correct identification of at least one of the 
characteristics that differentiated the packaging of generic drugs from other drugs. 
g Wald test for the linear trend and ordinal variables.
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(PR = 1.20; 95%CI 1.05–1.38). Skin color/race and the use of drugs for chronic or eventual 
diseases were not associated with the preference for purchasing generic drugs (Table 2). 
Among those who had good knowledge about generic drugs, 77.7% had a preference for 
purchasing them, whereas this proportion was only 18.4% among those with bad knowledge 
(p < 0.001). After adjustment, there was a trend of increasing preference for purchasing 
generic drugs as the knowledge about them increased (p < 0.001). Participants who answered 
correctly the three questions about the drugs were more likely to prefer generic drugs 
(PR = 4.66; 95%CI 2.89–7.52) (Table 2). 
Figure 2 shows the different strategies used to purchase drugs among those who prefer and 
do not prefer generic drugs. In general, those who did not prefer them tended to buy the 
medicine that was prescribed (75.7%) regardless of being a generic or not. However, 18% 
still ended up replacing the medicine prescribed by the generic drug. In addition, the main 
strategy used by those who preferred generic drugs was substitution (55.1%). 
Figure 3 shows the preference for purchasing generic drugs according to the knowledge of 
its characteristics. After controlling for demographic and socioeconomic variables, those 
who knew that the generic drug was cheaper than the reference one had a higher preference 
for purchasing generic drugs (51%; 95%CI 33–72) than those who were not aware of this 
difference in price. Those who had knowledge of the equivalent quality of generic drugs 
were 115% more likely to prefer generic drugs than those who did not know (95%CI 93–141). 
Those who correctly identified the characteristics that distinguish generic drugs from other 
medicines preferred the generic ones (26%; 95%CI 15–39). 
Figure 2. Strategies used to purchase drugs among those with preference and not preference for the 
generic drug. Pelotas, State of Rio Grande do Sul, Brazil, 2012. (n = 2,856)
%
Buy only the
prescribed 
drug
37.1
75.7
Replace the 
prescribed drug 
only by generic drug
55.1
17.8
Replace the 
prescribed drug 
by cheaper drug
7.8 6.5
Preference No preference
0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
PR: crude Prevalence Ratio
* Prevalence ratio adjusted for sex, age, education, and socioeconomic position (p < 0.001).
Figure 3. Preference for purchasing generic drugs according to knowledge about generic drugs. Pelotas, 
State of Rio Grande do Sul, Brazil, 2012. 
0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
…lower price … equivalent quality … characteristics that 
differentiate the packaging 
of generic drugs from other drugs
43.7
65.8
75.5
34.7
52.2
66.5
%
PR 1.51 (1.33–1.71)
PR* 1.51 (1.33–1.72)
PR 2.17 (1.95–2.42)
PR* 2.15 (1.93–2.41)
PR 1.43 (1.28–1.59)
PR* 1.26 (1.15–1.39)
Have no knowledge that generic drugs have… Have knowledge that generic drugs have…
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DISCUSSION 
The preference for purchasing generic drugs found in our study was similar to the one 
reported in another research conducted in Brazil, which has indicated that 68% of Brazilians 
preferred to use generic drugsc. A study performed in 2007 study found a preference of 
60.7%35. These findings may suggest an increased acceptance of generic medicines in Brazil. 
However, it is known that the hypothetical preference or positive attitude towards generic 
drugs does not necessarily translate into consumption in itself16. In addition, users can prefer 
the generic drug, but in the moment of purchase they can choose the similar drug, because 
of other factors such as price, supply, or availability. 
According to the hierarchical model of analysis, the proximal variables had more effect on 
the preference than distal variables (Figure 1). The main factors affecting the preference for 
purchasing generic drugs were the socioeconomic characteristics, especially those related 
to perception and knowledge about generic drugs. In this regard, data in the literature are 
contradictory16,29,31. Differences in contexts, health policies, and financial incentives may 
have contributed to these contradictory findings. 
Some studies have found results similar to ours, with respect to age1 including a review by 
Hassali et al.16, covering data from 1970 to 2008 for middle- and high-income individuals. 
However, Shrank et al.31 has found that, in Columbia, USA, younger persons were those who 
were less likely to prefer generic drugs. 
Regarding sex in our study, more men preferred generic drugs, whereas Alujer et al.1 and 
Shrank et al.31 have found no sex differences in the preference for generic drugs in their studies 
in Albaceta (Spain) and Columbia (USA), respectively. Differences regarding sex could be 
due to the largest proportion of losses among males, which could have skewed the results 
because of sampling bias. 
In terms of education, our findings are similar to those reported by Hassali et al.16, who have 
found that those with less education had more negative attitudes towards generic drugs. 
Regarding the socioeconomic position, our findings differ from the literature. While in our 
study the wealthiest class had lower preference for purchasing generic drugs, in the studies 
by Hassali et al.16 and Shrank et al.31, richer participants showed greater preference for the 
use of generic drugs than poorer participants. The results of our study showed a positive 
association between knowledge of generic drugs and purchase preference. In the study of 
Quintal et al.29 carried out with medicine users and pharmacists, they have been observed 
that the lack of information received by the user, lack of prescription, and lack of confidence 
in generic medicines were the main reasons for the underuse of generic drugs. 
By observing the specific knowledge about price, quality, or characteristics of the packaging, 
we can note that those with better knowledge about generic drugs have higher preference for 
purchasing them, being the perception on equivalent quality the main determinant factor 
in the choice of generic drugs, similar to the findings of other studies13,32. Keenum et al.22 
have observed that most participants agreed that generic drugs were cheaper (98%), were 
as effective as the reference medicine (77%), and reported not caring about the replacement 
(80%); but only 45% said they preferred generic drugs over brand name drugs22. This may be 
due to some prior negative experiences or guidance received from the prescriber36. This is 
similar to our finding that 18% of those who do not prefer generic drugs end up replacing the 
prescribed drug by the equivalent generic drug. Factors related to the behavior of consumers, 
prices, or even the suggestions of clerks may be influencing this choice. A study conducted 
in Brazil has shown differences on the perceptions regarding generic drugs28. Nardi et al.28 
have pointed out price, effectiveness, and safety as important factors that may contribute 
to the decision to purchase generic drugs. 
Another important barrier to increased use of generic drugs is the belief that generic drugs 
are less effective3. Although most persons accept the replacement, many do not accept it 
because they “believe that it does not have the same effect” or “it differs from the reference 
c Instituto de Ciência, Tecnoilogia 
e Qualidade, Departamento de 
Pesquisa. Hábitos de consumo 
de medicamentos. São Paulo: 
ICQT; 2013. 
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drug in pharmacology aspects”1. Many users remain skeptical because of the lower price of 
generic drugs, associating it with lower quality17. 
One limitation of our study was that the sample was representative of one medium-sized 
city in Southern Brazil, and not the entire country. Pelotas tends to present better economic 
indicators than the national mean18,19. This characteristic limits the extrapolation of our 
findings to the entire country, but the data presented here are appropriate to point out 
directions for campaigns aiming at the expansion of the acceptance and use of generic 
medicine. We were able to indicate the main factors affecting the acceptance of generic 
drugs, which are the perception of users and the knowledge on the quality of these products.
Although we found great influence from the knowledge of those who prefer generic drugs, 
in cross-sectional studies, some results are difficult to explain because of reverse causality. 
However, evidence from our study and from the literature has shown that preference is 
influenced by knowledge14,32. 
Additionally, we could not assess other aspects that may influence the preference for purchasing 
generic drugs, such as: user perception regarding the safety, efficacy, and effectiveness of generic 
drugs; previous experiences; preference of prescribers and their influence on the user; financial 
support; variables related to the use of health system; drug dispensing; and acceptance and 
knowledge of physicians about generic drugs. In this study, the preference for purchasing 
generic drugs was limited to individual factors. Studies have shown that prescribers have an 
important role in influencing the preference of users for generic drugs1,10. Despite having a 
more negative opinion than pharmacists about generic drugs10, the number of physicians who 
prescribe generic drugs has increased in Brazil in recent years9,33. 
Another limitation of our study was the possible induced positive answer for the outcome 
because of the order that questions were applied. We reduced this limitation using a direct 
question to measure the outcome. 
In this study, we assumed knowledge as being aware of the technical principles that 
generic drugs are cheaper and equivalent in terms of quality as compared to reference 
medicines. However, there are exceptions; for instance, a person may have experienced 
more expensive generic drugs than the reference product, because of market competition 
strategies. In addition, a product will hardly be effective in all cases. When the ineffectiveness 
is experienced with a generic, this negative experience can reinforce the belief of a lower 
quality. Thus, we find it appropriate to combine aspects of perception and knowledge to 
express both the technical aspects (price and quality) of generic drugs and their translation 
in the experience of users, which can affect their perception from personal experience or 
from persons around them. 
In conclusion, those who showed lower preference for generic drugs were women, older 
adults, users with lower education, and those with a high asset index. We also observed 
that the greater the knowledge or positive perception about generic drugs, the greater the 
preference to purchase this product. Thus, educational campaigns for healthcare professionals 
and consumers seem to be the best strategy to expand the use of such products, especially 
with regard to clarifications on quality. This needs to be paired with policies to ensure the 
supply of generic drugs at the cheapest prices among all medicines available in the market. 
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